Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure
Healthcare operations veteran with over 23 years of experience to lead key initiatives across South India
Expands manufacturing push & locks in major growth deals
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Hair care & quick commerce shine
Subscribe To Our Newsletter & Stay Updated
